Medical Care
Global Oncology Small Molecule Drugs Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 1986
- Pages: 125
- Figures: 156
- Views: 1
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths.
Market Analysis and Insights: Global Oncology Small Molecule Drugs Market
The global Oncology Small Molecule Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oncology Small Molecule Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oncology Small Molecule Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Oncology Small Molecule Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Oncology Small Molecule Drugs include Roche, Novartis, Pfizer, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, AbbVie and Sanofi, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Oncology Small Molecule Drugs is widely used in various fields, such as Blood Cancer, Breast Cancer, Gastrointestinal Cancer and Prostate Cancer, etc. Blood Cancer provides greatest supports to the Oncology Small Molecule Drugs industry development. In 2023, global % revenue of Oncology Small Molecule Drugs went into Blood Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Oncology Small Molecule Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oncology Small Molecule Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oncology Small Molecule Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncology Small Molecule Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oncology Small Molecule Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oncology Small Molecule Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Roche
Novartis
Pfizer
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
AbbVie
Sanofi
Takeda
Eli Lilly
Bayer
AstraZeneca
Astellas
Merck
Biogen Idec
Eisai
Teva
Otsuka
Ipsen
Gilead Sciences
Exelixis
Segment by Type
Chemotherapy Drugs
Immunomodulating Drugs
Targeted Therapy Drugs
Hormonal Therapy
Other
Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Lung Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oncology Small Molecule Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Small Molecule Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Small Molecule Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Oncology Small Molecule Drugs Market
The global Oncology Small Molecule Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oncology Small Molecule Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Oncology Small Molecule Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Oncology Small Molecule Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Oncology Small Molecule Drugs include Roche, Novartis, Pfizer, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, AbbVie and Sanofi, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Oncology Small Molecule Drugs is widely used in various fields, such as Blood Cancer, Breast Cancer, Gastrointestinal Cancer and Prostate Cancer, etc. Blood Cancer provides greatest supports to the Oncology Small Molecule Drugs industry development. In 2023, global % revenue of Oncology Small Molecule Drugs went into Blood Cancer filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Oncology Small Molecule Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oncology Small Molecule Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oncology Small Molecule Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncology Small Molecule Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oncology Small Molecule Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oncology Small Molecule Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Roche
Novartis
Pfizer
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
AbbVie
Sanofi
Takeda
Eli Lilly
Bayer
AstraZeneca
Astellas
Merck
Biogen Idec
Eisai
Teva
Otsuka
Ipsen
Gilead Sciences
Exelixis
Segment by Type
Chemotherapy Drugs
Immunomodulating Drugs
Targeted Therapy Drugs
Hormonal Therapy
Other
Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Lung Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oncology Small Molecule Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Small Molecule Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Small Molecule Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chemotherapy Drugs
1.2.3 Immunomodulating Drugs
1.2.4 Targeted Therapy Drugs
1.2.5 Hormonal Therapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Small Molecule Drugs Market Perspective (2019-2030)
2.2 Global Oncology Small Molecule Drugs Growth Trends by Region
2.2.1 Oncology Small Molecule Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncology Small Molecule Drugs Historic Market Size by Region (2019-2024)
2.2.3 Oncology Small Molecule Drugs Forecasted Market Size by Region (2025-2030)
2.3 Oncology Small Molecule Drugs Market Dynamics
2.3.1 Oncology Small Molecule Drugs Industry Trends
2.3.2 Oncology Small Molecule Drugs Market Drivers
2.3.3 Oncology Small Molecule Drugs Market Challenges
2.3.4 Oncology Small Molecule Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oncology Small Molecule Drugs by Players
3.1.1 Global Oncology Small Molecule Drugs Revenue by Players (2019-2024)
3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oncology Small Molecule Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Oncology Small Molecule Drugs Market Concentration Ratio
3.4.1 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Small Molecule Drugs Revenue in 2023
3.5 Global Key Players of Oncology Small Molecule Drugs Head office and Area Served
3.6 Global Key Players of Oncology Small Molecule Drugs, Product and Application
3.7 Global Key Players of Oncology Small Molecule Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Small Molecule Drugs Breakdown Data by Type
4.1 Global Oncology Small Molecule Drugs Historic Market Size by Type (2019-2024)
4.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2025-2030)
5 Oncology Small Molecule Drugs Breakdown Data by Application
5.1 Global Oncology Small Molecule Drugs Historic Market Size by Application (2019-2024)
5.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncology Small Molecule Drugs Market Size (2019-2030)
6.2 North America Oncology Small Molecule Drugs Market Size by Type
6.2.1 North America Oncology Small Molecule Drugs Market Size by Type (2019-2024)
6.2.2 North America Oncology Small Molecule Drugs Market Size by Type (2025-2030)
6.2.3 North America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
6.3 North America Oncology Small Molecule Drugs Market Size by Application
6.3.1 North America Oncology Small Molecule Drugs Market Size by Application (2019-2024)
6.3.2 North America Oncology Small Molecule Drugs Market Size by Application (2025-2030)
6.3.3 North America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
6.4 North America Oncology Small Molecule Drugs Market Size by Country
6.4.1 North America Oncology Small Molecule Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Oncology Small Molecule Drugs Market Size by Country (2019-2024)
6.4.3 North America Oncology Small Molecule Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oncology Small Molecule Drugs Market Size (2019-2030)
7.2 Europe Oncology Small Molecule Drugs Market Size by Type
7.2.1 Europe Oncology Small Molecule Drugs Market Size by Type (2019-2024)
7.2.2 Europe Oncology Small Molecule Drugs Market Size by Type (2025-2030)
7.2.3 Europe Oncology Small Molecule Drugs Market Share by Type (2019-2030)
7.3 Europe Oncology Small Molecule Drugs Market Size by Application
7.3.1 Europe Oncology Small Molecule Drugs Market Size by Application (2019-2024)
7.3.2 Europe Oncology Small Molecule Drugs Market Size by Application (2025-2030)
7.3.3 Europe Oncology Small Molecule Drugs Market Share by Application (2019-2030)
7.4 Europe Oncology Small Molecule Drugs Market Size by Country
7.4.1 Europe Oncology Small Molecule Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Oncology Small Molecule Drugs Market Size by Country (2019-2024)
7.4.3 Europe Oncology Small Molecule Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oncology Small Molecule Drugs Market Size (2019-2030)
8.2 China Oncology Small Molecule Drugs Market Size by Type
8.2.1 China Oncology Small Molecule Drugs Market Size by Type (2019-2024)
8.2.2 China Oncology Small Molecule Drugs Market Size by Type (2025-2030)
8.2.3 China Oncology Small Molecule Drugs Market Share by Type (2019-2030)
8.3 China Oncology Small Molecule Drugs Market Size by Application
8.3.1 China Oncology Small Molecule Drugs Market Size by Application (2019-2024)
8.3.2 China Oncology Small Molecule Drugs Market Size by Application (2025-2030)
8.3.3 China Oncology Small Molecule Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Oncology Small Molecule Drugs Market Size (2019-2030)
9.2 Asia Oncology Small Molecule Drugs Market Size by Type
9.2.1 Asia Oncology Small Molecule Drugs Market Size by Type (2019-2024)
9.2.2 Asia Oncology Small Molecule Drugs Market Size by Type (2025-2030)
9.2.3 Asia Oncology Small Molecule Drugs Market Share by Type (2019-2030)
9.3 Asia Oncology Small Molecule Drugs Market Size by Application
9.3.1 Asia Oncology Small Molecule Drugs Market Size by Application (2019-2024)
9.3.2 Asia Oncology Small Molecule Drugs Market Size by Application (2025-2030)
9.3.3 Asia Oncology Small Molecule Drugs Market Share by Application (2019-2030)
9.4 Asia Oncology Small Molecule Drugs Market Size by Region
9.4.1 Asia Oncology Small Molecule Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Oncology Small Molecule Drugs Market Size by Region (2019-2024)
9.4.3 Asia Oncology Small Molecule Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Small Molecule Drugs Introduction
11.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Oncology Small Molecule Drugs Introduction
11.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oncology Small Molecule Drugs Introduction
11.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.3.5 Pfizer Recent Developments
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Oncology Small Molecule Drugs Introduction
11.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.4.5 Celgene Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Introduction
11.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Oncology Small Molecule Drugs Introduction
11.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.6.5 Amgen Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.7.5 Johnson & Johnson Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Oncology Small Molecule Drugs Introduction
11.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.8.5 AbbVie Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Oncology Small Molecule Drugs Introduction
11.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.9.5 Sanofi Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Oncology Small Molecule Drugs Introduction
11.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.10.5 Takeda Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Oncology Small Molecule Drugs Introduction
11.11.4 Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.11.5 Eli Lilly Recent Developments
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Oncology Small Molecule Drugs Introduction
11.12.4 Bayer Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.12.5 Bayer Recent Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Oncology Small Molecule Drugs Introduction
11.13.4 AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.13.5 AstraZeneca Recent Developments
11.14 Astellas
11.14.1 Astellas Company Details
11.14.2 Astellas Business Overview
11.14.3 Astellas Oncology Small Molecule Drugs Introduction
11.14.4 Astellas Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.14.5 Astellas Recent Developments
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck Oncology Small Molecule Drugs Introduction
11.15.4 Merck Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.15.5 Merck Recent Developments
11.16 Biogen Idec
11.16.1 Biogen Idec Company Details
11.16.2 Biogen Idec Business Overview
11.16.3 Biogen Idec Oncology Small Molecule Drugs Introduction
11.16.4 Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.16.5 Biogen Idec Recent Developments
11.17 Eisai
11.17.1 Eisai Company Details
11.17.2 Eisai Business Overview
11.17.3 Eisai Oncology Small Molecule Drugs Introduction
11.17.4 Eisai Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.17.5 Eisai Recent Developments
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Small Molecule Drugs Introduction
11.18.4 Teva Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.18.5 Teva Recent Developments
11.19 Otsuka
11.19.1 Otsuka Company Details
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Oncology Small Molecule Drugs Introduction
11.19.4 Otsuka Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.19.5 Otsuka Recent Developments
11.20 Ipsen
11.20.1 Ipsen Company Details
11.20.2 Ipsen Business Overview
11.20.3 Ipsen Oncology Small Molecule Drugs Introduction
11.20.4 Ipsen Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.20.5 Ipsen Recent Developments
11.21 Gilead Sciences
11.21.1 Gilead Sciences Company Details
11.21.2 Gilead Sciences Business Overview
11.21.3 Gilead Sciences Oncology Small Molecule Drugs Introduction
11.21.4 Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.21.5 Gilead Sciences Recent Developments
11.22 Exelixis
11.22.1 Exelixis Company Details
11.22.2 Exelixis Business Overview
11.22.3 Exelixis Oncology Small Molecule Drugs Introduction
11.22.4 Exelixis Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.22.5 Exelixis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chemotherapy Drugs
1.2.3 Immunomodulating Drugs
1.2.4 Targeted Therapy Drugs
1.2.5 Hormonal Therapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Small Molecule Drugs Market Perspective (2019-2030)
2.2 Global Oncology Small Molecule Drugs Growth Trends by Region
2.2.1 Oncology Small Molecule Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncology Small Molecule Drugs Historic Market Size by Region (2019-2024)
2.2.3 Oncology Small Molecule Drugs Forecasted Market Size by Region (2025-2030)
2.3 Oncology Small Molecule Drugs Market Dynamics
2.3.1 Oncology Small Molecule Drugs Industry Trends
2.3.2 Oncology Small Molecule Drugs Market Drivers
2.3.3 Oncology Small Molecule Drugs Market Challenges
2.3.4 Oncology Small Molecule Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oncology Small Molecule Drugs by Players
3.1.1 Global Oncology Small Molecule Drugs Revenue by Players (2019-2024)
3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oncology Small Molecule Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Oncology Small Molecule Drugs Market Concentration Ratio
3.4.1 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Small Molecule Drugs Revenue in 2023
3.5 Global Key Players of Oncology Small Molecule Drugs Head office and Area Served
3.6 Global Key Players of Oncology Small Molecule Drugs, Product and Application
3.7 Global Key Players of Oncology Small Molecule Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Small Molecule Drugs Breakdown Data by Type
4.1 Global Oncology Small Molecule Drugs Historic Market Size by Type (2019-2024)
4.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2025-2030)
5 Oncology Small Molecule Drugs Breakdown Data by Application
5.1 Global Oncology Small Molecule Drugs Historic Market Size by Application (2019-2024)
5.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncology Small Molecule Drugs Market Size (2019-2030)
6.2 North America Oncology Small Molecule Drugs Market Size by Type
6.2.1 North America Oncology Small Molecule Drugs Market Size by Type (2019-2024)
6.2.2 North America Oncology Small Molecule Drugs Market Size by Type (2025-2030)
6.2.3 North America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
6.3 North America Oncology Small Molecule Drugs Market Size by Application
6.3.1 North America Oncology Small Molecule Drugs Market Size by Application (2019-2024)
6.3.2 North America Oncology Small Molecule Drugs Market Size by Application (2025-2030)
6.3.3 North America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
6.4 North America Oncology Small Molecule Drugs Market Size by Country
6.4.1 North America Oncology Small Molecule Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Oncology Small Molecule Drugs Market Size by Country (2019-2024)
6.4.3 North America Oncology Small Molecule Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Oncology Small Molecule Drugs Market Size (2019-2030)
7.2 Europe Oncology Small Molecule Drugs Market Size by Type
7.2.1 Europe Oncology Small Molecule Drugs Market Size by Type (2019-2024)
7.2.2 Europe Oncology Small Molecule Drugs Market Size by Type (2025-2030)
7.2.3 Europe Oncology Small Molecule Drugs Market Share by Type (2019-2030)
7.3 Europe Oncology Small Molecule Drugs Market Size by Application
7.3.1 Europe Oncology Small Molecule Drugs Market Size by Application (2019-2024)
7.3.2 Europe Oncology Small Molecule Drugs Market Size by Application (2025-2030)
7.3.3 Europe Oncology Small Molecule Drugs Market Share by Application (2019-2030)
7.4 Europe Oncology Small Molecule Drugs Market Size by Country
7.4.1 Europe Oncology Small Molecule Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Oncology Small Molecule Drugs Market Size by Country (2019-2024)
7.4.3 Europe Oncology Small Molecule Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oncology Small Molecule Drugs Market Size (2019-2030)
8.2 China Oncology Small Molecule Drugs Market Size by Type
8.2.1 China Oncology Small Molecule Drugs Market Size by Type (2019-2024)
8.2.2 China Oncology Small Molecule Drugs Market Size by Type (2025-2030)
8.2.3 China Oncology Small Molecule Drugs Market Share by Type (2019-2030)
8.3 China Oncology Small Molecule Drugs Market Size by Application
8.3.1 China Oncology Small Molecule Drugs Market Size by Application (2019-2024)
8.3.2 China Oncology Small Molecule Drugs Market Size by Application (2025-2030)
8.3.3 China Oncology Small Molecule Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Oncology Small Molecule Drugs Market Size (2019-2030)
9.2 Asia Oncology Small Molecule Drugs Market Size by Type
9.2.1 Asia Oncology Small Molecule Drugs Market Size by Type (2019-2024)
9.2.2 Asia Oncology Small Molecule Drugs Market Size by Type (2025-2030)
9.2.3 Asia Oncology Small Molecule Drugs Market Share by Type (2019-2030)
9.3 Asia Oncology Small Molecule Drugs Market Size by Application
9.3.1 Asia Oncology Small Molecule Drugs Market Size by Application (2019-2024)
9.3.2 Asia Oncology Small Molecule Drugs Market Size by Application (2025-2030)
9.3.3 Asia Oncology Small Molecule Drugs Market Share by Application (2019-2030)
9.4 Asia Oncology Small Molecule Drugs Market Size by Region
9.4.1 Asia Oncology Small Molecule Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Oncology Small Molecule Drugs Market Size by Region (2019-2024)
9.4.3 Asia Oncology Small Molecule Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Small Molecule Drugs Introduction
11.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Oncology Small Molecule Drugs Introduction
11.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oncology Small Molecule Drugs Introduction
11.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.3.5 Pfizer Recent Developments
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Oncology Small Molecule Drugs Introduction
11.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.4.5 Celgene Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Introduction
11.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Oncology Small Molecule Drugs Introduction
11.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.6.5 Amgen Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.7.5 Johnson & Johnson Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Oncology Small Molecule Drugs Introduction
11.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.8.5 AbbVie Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Oncology Small Molecule Drugs Introduction
11.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.9.5 Sanofi Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Oncology Small Molecule Drugs Introduction
11.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.10.5 Takeda Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Oncology Small Molecule Drugs Introduction
11.11.4 Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.11.5 Eli Lilly Recent Developments
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Oncology Small Molecule Drugs Introduction
11.12.4 Bayer Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.12.5 Bayer Recent Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Oncology Small Molecule Drugs Introduction
11.13.4 AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.13.5 AstraZeneca Recent Developments
11.14 Astellas
11.14.1 Astellas Company Details
11.14.2 Astellas Business Overview
11.14.3 Astellas Oncology Small Molecule Drugs Introduction
11.14.4 Astellas Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.14.5 Astellas Recent Developments
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck Oncology Small Molecule Drugs Introduction
11.15.4 Merck Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.15.5 Merck Recent Developments
11.16 Biogen Idec
11.16.1 Biogen Idec Company Details
11.16.2 Biogen Idec Business Overview
11.16.3 Biogen Idec Oncology Small Molecule Drugs Introduction
11.16.4 Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.16.5 Biogen Idec Recent Developments
11.17 Eisai
11.17.1 Eisai Company Details
11.17.2 Eisai Business Overview
11.17.3 Eisai Oncology Small Molecule Drugs Introduction
11.17.4 Eisai Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.17.5 Eisai Recent Developments
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Small Molecule Drugs Introduction
11.18.4 Teva Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.18.5 Teva Recent Developments
11.19 Otsuka
11.19.1 Otsuka Company Details
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Oncology Small Molecule Drugs Introduction
11.19.4 Otsuka Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.19.5 Otsuka Recent Developments
11.20 Ipsen
11.20.1 Ipsen Company Details
11.20.2 Ipsen Business Overview
11.20.3 Ipsen Oncology Small Molecule Drugs Introduction
11.20.4 Ipsen Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.20.5 Ipsen Recent Developments
11.21 Gilead Sciences
11.21.1 Gilead Sciences Company Details
11.21.2 Gilead Sciences Business Overview
11.21.3 Gilead Sciences Oncology Small Molecule Drugs Introduction
11.21.4 Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.21.5 Gilead Sciences Recent Developments
11.22 Exelixis
11.22.1 Exelixis Company Details
11.22.2 Exelixis Business Overview
11.22.3 Exelixis Oncology Small Molecule Drugs Introduction
11.22.4 Exelixis Revenue in Oncology Small Molecule Drugs Business (2019-2024)
11.22.5 Exelixis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Immunomodulating Drugs
Table 4. Key Players of Targeted Therapy Drugs
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Other
Table 7. Global Oncology Small Molecule Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Global Oncology Small Molecule Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Oncology Small Molecule Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Oncology Small Molecule Drugs Market Share by Region (2019-2024)
Table 11. Global Oncology Small Molecule Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Oncology Small Molecule Drugs Market Share by Region (2025-2030)
Table 13. Oncology Small Molecule Drugs Market Trends
Table 14. Oncology Small Molecule Drugs Market Drivers
Table 15. Oncology Small Molecule Drugs Market Challenges
Table 16. Oncology Small Molecule Drugs Market Restraints
Table 17. Global Oncology Small Molecule Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Oncology Small Molecule Drugs Revenue Share by Players (2019-2024)
Table 19. Global Top Oncology Small Molecule Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2023)
Table 20. Global Oncology Small Molecule Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 21. Global 5 Largest Players Market Share by Oncology Small Molecule Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Oncology Small Molecule Drugs, Headquarters and Area Served
Table 23. Global Key Players of Oncology Small Molecule Drugs, Product and Application
Table 24. Global Key Players of Oncology Small Molecule Drugs, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2019-2024)
Table 28. Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2025-2030)
Table 30. Global Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Oncology Small Molecule Drugs Revenue Share by Application (2019-2024)
Table 32. Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Oncology Small Molecule Drugs Revenue Share by Application (2025-2030)
Table 34. North America Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 35. North America Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 36. North America Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 37. North America Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 38. North America Oncology Small Molecule Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America Oncology Small Molecule Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America Oncology Small Molecule Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 42. Europe Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 43. Europe Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 44. Europe Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 45. Europe Oncology Small Molecule Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Europe Oncology Small Molecule Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Europe Oncology Small Molecule Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. China Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 49. China Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 50. China Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 51. China Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 52. Asia Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 53. Asia Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 54. Asia Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 55. Asia Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 56. Asia Oncology Small Molecule Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 57. Asia Oncology Small Molecule Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 58. Asia Oncology Small Molecule Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 64. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Oncology Small Molecule Drugs Product
Table 69. Roche Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 70. Roche Recent Developments
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Oncology Small Molecule Drugs Product
Table 74. Novartis Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 75. Novartis Recent Developments
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Oncology Small Molecule Drugs Product
Table 79. Pfizer Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 80. Pfizer Recent Developments
Table 81. Celgene Company Details
Table 82. Celgene Business Overview
Table 83. Celgene Oncology Small Molecule Drugs Product
Table 84. Celgene Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 85. Celgene Recent Developments
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Oncology Small Molecule Drugs Product
Table 89. Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Oncology Small Molecule Drugs Product
Table 94. Amgen Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 95. Amgen Recent Developments
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Oncology Small Molecule Drugs Product
Table 99. Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 100. Johnson & Johnson Recent Developments
Table 101. AbbVie Company Details
Table 102. AbbVie Business Overview
Table 103. AbbVie Oncology Small Molecule Drugs Product
Table 104. AbbVie Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 105. AbbVie Recent Developments
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Oncology Small Molecule Drugs Product
Table 109. Sanofi Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 110. Sanofi Recent Developments
Table 111. Takeda Company Details
Table 112. Takeda Business Overview
Table 113. Takeda Oncology Small Molecule Drugs Product
Table 114. Takeda Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 115. Takeda Recent Developments
Table 116. Eli Lilly Company Details
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Oncology Small Molecule Drugs Product
Table 119. Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 120. Eli Lilly Recent Developments
Table 121. Bayer Company Details
Table 122. Bayer Business Overview
Table 123. Bayer Oncology Small Molecule Drugs Product
Table 124. Bayer Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 125. Bayer Recent Developments
Table 126. AstraZeneca Company Details
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Oncology Small Molecule Drugs Product
Table 129. AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 130. AstraZeneca Recent Developments
Table 131. Astellas Company Details
Table 132. Astellas Business Overview
Table 133. Astellas Oncology Small Molecule Drugs Product
Table 134. Astellas Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 135. Astellas Recent Developments
Table 136. Merck Company Details
Table 137. Merck Business Overview
Table 138. Merck Oncology Small Molecule Drugs Product
Table 139. Merck Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 140. Merck Recent Developments
Table 141. Biogen Idec Company Details
Table 142. Biogen Idec Business Overview
Table 143. Biogen Idec Oncology Small Molecule Drugs Product
Table 144. Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 145. Biogen Idec Recent Developments
Table 146. Eisai Company Details
Table 147. Eisai Business Overview
Table 148. Eisai Oncology Small Molecule Drugs Product
Table 149. Eisai Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 150. Eisai Recent Developments
Table 151. Teva Company Details
Table 152. Teva Business Overview
Table 153. Teva Oncology Small Molecule Drugs Product
Table 154. Teva Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 155. Teva Recent Developments
Table 156. Otsuka Company Details
Table 157. Otsuka Business Overview
Table 158. Otsuka Oncology Small Molecule Drugs Product
Table 159. Otsuka Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 160. Otsuka Recent Developments
Table 161. Ipsen Company Details
Table 162. Ipsen Business Overview
Table 163. Ipsen Oncology Small Molecule Drugs Product
Table 164. Ipsen Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 165. Ipsen Recent Developments
Table 166. Gilead Sciences Company Details
Table 167. Gilead Sciences Business Overview
Table 168. Gilead Sciences Oncology Small Molecule Drugs Product
Table 169. Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 170. Gilead Sciences Recent Developments
Table 171. Exelixis Company Details
Table 172. Exelixis Business Overview
Table 173. Exelixis Oncology Small Molecule Drugs Product
Table 174. Exelixis Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 175. Exelixis Recent Developments
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Oncology Small Molecule Drugs Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Drugs Features
Figure 4. Immunomodulating Drugs Features
Figure 5. Targeted Therapy Drugs Features
Figure 6. Hormonal Therapy Features
Figure 7. Other Features
Figure 8. Global Oncology Small Molecule Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Oncology Small Molecule Drugs Market Share by Application: 2023 VS 2030
Figure 10. Blood Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Gastrointestinal Cancer Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Lung Cancer Case Studies
Figure 15. Other Case Studies
Figure 16. Oncology Small Molecule Drugs Report Years Considered
Figure 17. Global Oncology Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Oncology Small Molecule Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Oncology Small Molecule Drugs Market Share by Region: 2023 VS 2030
Figure 20. Global Oncology Small Molecule Drugs Market Share by Players in 2023
Figure 21. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Oncology Small Molecule Drugs Revenue in 2023
Figure 23. North America Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 25. North America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 26. North America Oncology Small Molecule Drugs Market Share by Country (2019-2030)
Figure 27. United States Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 30. Europe Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 31. Europe Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 32. Europe Oncology Small Molecule Drugs Market Share by Country (2019-2030)
Figure 33. Germany Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. China Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 40. China Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 41. China Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 42. Asia Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 43. Asia Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 44. Asia Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 45. Asia Oncology Small Molecule Drugs Market Share by Region (2019-2030)
Figure 46. Japan Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. South Korea Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. China Taiwan Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. India Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Australia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 54. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 55. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Country (2019-2030)
Figure 56. Brazil Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Mexico Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Turkey Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Israel Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. GCC Countries Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 62. Roche Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 63. Novartis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 64. Pfizer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 65. Celgene Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 67. Amgen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 68. Johnson & Johnson Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 69. AbbVie Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 70. Sanofi Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 71. Takeda Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 72. Eli Lilly Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 73. Bayer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 74. AstraZeneca Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 75. Astellas Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 76. Merck Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 77. Biogen Idec Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 78. Eisai Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 79. Teva Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 80. Otsuka Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 81. Ipsen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 82. Gilead Sciences Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 83. Exelixis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Table 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Immunomodulating Drugs
Table 4. Key Players of Targeted Therapy Drugs
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Other
Table 7. Global Oncology Small Molecule Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 8. Global Oncology Small Molecule Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Oncology Small Molecule Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Oncology Small Molecule Drugs Market Share by Region (2019-2024)
Table 11. Global Oncology Small Molecule Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Oncology Small Molecule Drugs Market Share by Region (2025-2030)
Table 13. Oncology Small Molecule Drugs Market Trends
Table 14. Oncology Small Molecule Drugs Market Drivers
Table 15. Oncology Small Molecule Drugs Market Challenges
Table 16. Oncology Small Molecule Drugs Market Restraints
Table 17. Global Oncology Small Molecule Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Oncology Small Molecule Drugs Revenue Share by Players (2019-2024)
Table 19. Global Top Oncology Small Molecule Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2023)
Table 20. Global Oncology Small Molecule Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 21. Global 5 Largest Players Market Share by Oncology Small Molecule Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Oncology Small Molecule Drugs, Headquarters and Area Served
Table 23. Global Key Players of Oncology Small Molecule Drugs, Product and Application
Table 24. Global Key Players of Oncology Small Molecule Drugs, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2019-2024)
Table 28. Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2025-2030)
Table 30. Global Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Oncology Small Molecule Drugs Revenue Share by Application (2019-2024)
Table 32. Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Oncology Small Molecule Drugs Revenue Share by Application (2025-2030)
Table 34. North America Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 35. North America Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 36. North America Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 37. North America Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 38. North America Oncology Small Molecule Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America Oncology Small Molecule Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America Oncology Small Molecule Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 42. Europe Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 43. Europe Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 44. Europe Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 45. Europe Oncology Small Molecule Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Europe Oncology Small Molecule Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Europe Oncology Small Molecule Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. China Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 49. China Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 50. China Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 51. China Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 52. Asia Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 53. Asia Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 54. Asia Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 55. Asia Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 56. Asia Oncology Small Molecule Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 57. Asia Oncology Small Molecule Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 58. Asia Oncology Small Molecule Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 64. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Oncology Small Molecule Drugs Product
Table 69. Roche Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 70. Roche Recent Developments
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Oncology Small Molecule Drugs Product
Table 74. Novartis Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 75. Novartis Recent Developments
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Oncology Small Molecule Drugs Product
Table 79. Pfizer Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 80. Pfizer Recent Developments
Table 81. Celgene Company Details
Table 82. Celgene Business Overview
Table 83. Celgene Oncology Small Molecule Drugs Product
Table 84. Celgene Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 85. Celgene Recent Developments
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Oncology Small Molecule Drugs Product
Table 89. Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Oncology Small Molecule Drugs Product
Table 94. Amgen Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 95. Amgen Recent Developments
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Oncology Small Molecule Drugs Product
Table 99. Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 100. Johnson & Johnson Recent Developments
Table 101. AbbVie Company Details
Table 102. AbbVie Business Overview
Table 103. AbbVie Oncology Small Molecule Drugs Product
Table 104. AbbVie Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 105. AbbVie Recent Developments
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Oncology Small Molecule Drugs Product
Table 109. Sanofi Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 110. Sanofi Recent Developments
Table 111. Takeda Company Details
Table 112. Takeda Business Overview
Table 113. Takeda Oncology Small Molecule Drugs Product
Table 114. Takeda Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 115. Takeda Recent Developments
Table 116. Eli Lilly Company Details
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Oncology Small Molecule Drugs Product
Table 119. Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 120. Eli Lilly Recent Developments
Table 121. Bayer Company Details
Table 122. Bayer Business Overview
Table 123. Bayer Oncology Small Molecule Drugs Product
Table 124. Bayer Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 125. Bayer Recent Developments
Table 126. AstraZeneca Company Details
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Oncology Small Molecule Drugs Product
Table 129. AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 130. AstraZeneca Recent Developments
Table 131. Astellas Company Details
Table 132. Astellas Business Overview
Table 133. Astellas Oncology Small Molecule Drugs Product
Table 134. Astellas Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 135. Astellas Recent Developments
Table 136. Merck Company Details
Table 137. Merck Business Overview
Table 138. Merck Oncology Small Molecule Drugs Product
Table 139. Merck Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 140. Merck Recent Developments
Table 141. Biogen Idec Company Details
Table 142. Biogen Idec Business Overview
Table 143. Biogen Idec Oncology Small Molecule Drugs Product
Table 144. Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 145. Biogen Idec Recent Developments
Table 146. Eisai Company Details
Table 147. Eisai Business Overview
Table 148. Eisai Oncology Small Molecule Drugs Product
Table 149. Eisai Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 150. Eisai Recent Developments
Table 151. Teva Company Details
Table 152. Teva Business Overview
Table 153. Teva Oncology Small Molecule Drugs Product
Table 154. Teva Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 155. Teva Recent Developments
Table 156. Otsuka Company Details
Table 157. Otsuka Business Overview
Table 158. Otsuka Oncology Small Molecule Drugs Product
Table 159. Otsuka Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 160. Otsuka Recent Developments
Table 161. Ipsen Company Details
Table 162. Ipsen Business Overview
Table 163. Ipsen Oncology Small Molecule Drugs Product
Table 164. Ipsen Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 165. Ipsen Recent Developments
Table 166. Gilead Sciences Company Details
Table 167. Gilead Sciences Business Overview
Table 168. Gilead Sciences Oncology Small Molecule Drugs Product
Table 169. Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 170. Gilead Sciences Recent Developments
Table 171. Exelixis Company Details
Table 172. Exelixis Business Overview
Table 173. Exelixis Oncology Small Molecule Drugs Product
Table 174. Exelixis Revenue in Oncology Small Molecule Drugs Business (2019-2024) & (US$ Million)
Table 175. Exelixis Recent Developments
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Oncology Small Molecule Drugs Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Drugs Features
Figure 4. Immunomodulating Drugs Features
Figure 5. Targeted Therapy Drugs Features
Figure 6. Hormonal Therapy Features
Figure 7. Other Features
Figure 8. Global Oncology Small Molecule Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Oncology Small Molecule Drugs Market Share by Application: 2023 VS 2030
Figure 10. Blood Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Gastrointestinal Cancer Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Lung Cancer Case Studies
Figure 15. Other Case Studies
Figure 16. Oncology Small Molecule Drugs Report Years Considered
Figure 17. Global Oncology Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Oncology Small Molecule Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Oncology Small Molecule Drugs Market Share by Region: 2023 VS 2030
Figure 20. Global Oncology Small Molecule Drugs Market Share by Players in 2023
Figure 21. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Oncology Small Molecule Drugs Revenue in 2023
Figure 23. North America Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 25. North America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 26. North America Oncology Small Molecule Drugs Market Share by Country (2019-2030)
Figure 27. United States Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 30. Europe Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 31. Europe Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 32. Europe Oncology Small Molecule Drugs Market Share by Country (2019-2030)
Figure 33. Germany Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. China Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 40. China Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 41. China Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 42. Asia Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 43. Asia Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 44. Asia Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 45. Asia Oncology Small Molecule Drugs Market Share by Region (2019-2030)
Figure 46. Japan Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. South Korea Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. China Taiwan Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. India Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Australia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Type (2019-2030)
Figure 54. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Application (2019-2030)
Figure 55. Middle East, Africa, and Latin America Oncology Small Molecule Drugs Market Share by Country (2019-2030)
Figure 56. Brazil Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Mexico Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Turkey Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Israel Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. GCC Countries Oncology Small Molecule Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 62. Roche Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 63. Novartis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 64. Pfizer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 65. Celgene Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 67. Amgen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 68. Johnson & Johnson Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 69. AbbVie Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 70. Sanofi Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 71. Takeda Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 72. Eli Lilly Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 73. Bayer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 74. AstraZeneca Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 75. Astellas Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 76. Merck Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 77. Biogen Idec Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 78. Eisai Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 79. Teva Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 80. Otsuka Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 81. Ipsen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 82. Gilead Sciences Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 83. Exelixis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2019-2024)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232